PortfoliosLab logo
Sanofi (SNY)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US80105N1054

CUSIP

80105N105

IPO Date

Jul 1, 2002

Highlights

Market Cap

$126.38B

EPS (TTM)

$2.79

PE Ratio

18.52

PEG Ratio

0.85

Total Revenue (TTM)

$43.77B

Gross Profit (TTM)

$31.12B

EBITDA (TTM)

$9.61B

Year Range

$43.86 - $57.57

Target Price

$65.08

Short %

0.16%

Short Ratio

1.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Sanofi (SNY) returned 11.90% year-to-date (YTD) and 10.89% over the past 12 months. Over the past 10 years, SNY returned 4.27% annually, underperforming the S&P 500 benchmark at 10.89%.


SNY

YTD

11.90%

1M

6.03%

6M

12.51%

1Y

10.89%

5Y*

5.79%

10Y*

4.27%

^GSPC (Benchmark)

YTD

1.30%

1M

12.79%

6M

1.49%

1Y

12.35%

5Y*

15.12%

10Y*

10.89%

*Annualized

Monthly Returns

The table below presents the monthly returns of SNY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202512.67%0.24%1.82%-0.92%-1.78%11.90%
20240.34%-4.11%1.57%1.30%3.81%-1.04%6.78%8.59%2.43%-8.24%-8.30%-0.54%1.09%
20231.47%-4.66%16.16%-1.41%-1.17%5.64%-0.98%-0.36%0.86%-15.64%3.31%6.37%6.71%
20223.79%0.87%-2.12%1.77%5.92%-6.05%-0.66%-17.44%-7.34%13.70%4.90%6.79%0.47%
2021-2.84%-2.80%7.78%5.88%5.88%-1.44%-2.09%0.43%-6.89%4.60%-5.67%5.32%7.00%
2020-3.84%-4.18%-5.47%11.09%4.87%3.95%2.74%-3.57%-0.81%-9.71%10.82%-3.21%0.38%
20190.09%-4.26%6.44%-1.24%-3.69%7.02%-3.63%3.00%7.87%-0.54%1.30%7.54%20.47%
20182.16%-10.65%2.11%-1.90%2.25%4.55%8.37%-1.18%4.25%0.11%1.41%-4.28%6.06%
20170.84%5.76%4.92%4.53%8.28%-3.39%-1.15%3.12%1.95%-5.04%-3.47%-5.78%9.82%
2016-2.37%-5.02%1.54%2.34%4.46%1.58%1.86%-9.76%-0.73%1.83%3.37%0.60%-1.19%
20151.05%6.01%1.19%2.25%1.00%0.24%9.00%-9.39%-2.96%6.05%-12.16%-3.55%-3.37%
2014-8.82%6.01%0.85%2.91%2.68%-0.24%-1.69%4.65%3.16%-18.06%4.43%-5.55%-11.86%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SNY is 62, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SNY is 6262
Overall Rank
The Sharpe Ratio Rank of SNY is 6868
Sharpe Ratio Rank
The Sortino Ratio Rank of SNY is 5757
Sortino Ratio Rank
The Omega Ratio Rank of SNY is 5555
Omega Ratio Rank
The Calmar Ratio Rank of SNY is 6969
Calmar Ratio Rank
The Martin Ratio Rank of SNY is 6363
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Sanofi (SNY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Sanofi Sharpe ratios as of May 18, 2025 (values are recalculated daily):

  • 1-Year: 0.43
  • 5-Year: 0.25
  • 10-Year: 0.18
  • All Time: 0.24

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Sanofi compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History

Sanofi provided a 4.28% dividend yield over the last twelve months, with an annual payout of $2.21 per share.


3.40%3.60%3.80%4.00%4.20%$0.00$0.50$1.00$1.50$2.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$2.21$2.04$1.90$2.04$1.91$1.75$1.74$1.86$1.58$1.63$1.62$1.91

Dividend yield

4.28%4.22%3.83%4.22%3.80%3.61%3.46%4.29%3.67%4.03%3.79%4.19%

Monthly Dividends

The table displays the monthly dividend distributions for Sanofi. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$2.21$2.21
2024$0.00$0.00$0.00$0.00$2.04$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.04
2023$0.00$0.00$0.00$0.00$1.90$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.90
2022$0.00$0.00$0.00$0.00$2.04$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.04
2021$0.00$0.00$0.00$0.00$1.91$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.91
2020$0.00$0.00$0.00$1.75$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.75
2019$0.00$0.00$0.00$0.00$1.74$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.74
2018$0.00$0.00$0.00$0.00$1.86$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.86
2017$0.00$0.00$0.00$0.00$1.58$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.58
2016$0.00$0.00$0.00$0.00$1.63$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.63
2015$0.00$0.00$0.00$0.00$1.62$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.62
2014$1.91$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.91

Dividend Yield & Payout


Dividend Yield

Sanofi has a dividend yield of 4.28%, which is quite average when compared to the overall market.

Payout Ratio

Sanofi has a payout ratio of 52.61%, which is quite average when compared to the overall market. This suggests that Sanofi strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Sanofi. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sanofi was 46.65%, occurring on Mar 6, 2009. Recovery took 586 trading sessions.

The current Sanofi drawdown is 9.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.65%Jul 27, 2006657Mar 6, 2009586Jul 1, 20111243
-33.52%May 25, 202286Sep 27, 2022136Apr 13, 2023222
-30.79%Sep 23, 2014350Feb 11, 2016936Oct 30, 20191286
-28.97%Aug 12, 2002129Feb 13, 200373May 30, 2003202
-26.4%Feb 7, 202030Mar 20, 202050Jun 2, 202080

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sanofi over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Sanofi, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 7.0% positive surprise.


1.001.502.002.5020212022202320242025
1.02
0.95
Actual
Estimate

Valuation

The Valuation section provides an overview of how Sanofi is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for SNY, comparing it with other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/E ratio of 18.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for SNY compared to other companies in the Drug Manufacturers - General industry. SNY currently has a PEG ratio of 0.9. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SNY relative to other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/S ratio of 2.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SNY in comparison with other companies in the Drug Manufacturers - General industry. Currently, SNY has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items